and 1970 for patients with a ruptured intracranial aneurysm. A life table method of statistical analysis was used to determine cumulative mortality znd rebleeding rate during a five-year follow-up period for 187 patients in this treatment program and for subgroups of this patient sample. Linear discriminant function analysis was used to develop equations of clinical variables to predict mortality and rebleeding during the 90-day period following the bleed.
S U M M A R Y Regulated bed rest was one of four treatment modalities evaluated in a randomized clinical trial conducted between 1963
and 1970 for patients with a ruptured intracranial aneurysm. A life table method of statistical analysis was used to determine cumulative mortality znd rebleeding rate during a five-year follow-up period for 187 patients in this treatment program and for subgroups of this patient sample. Linear discriminant function analysis was used to develop equations of clinical variables to predict mortality and rebleeding during the 90-day period following the bleed.
The clinical variables found to be most indicative of mortality included a poor initial neurological and medical state and sex (male). Other variables somewhat indicative of high mortality but not reaching statistical significance included a short interval from last bleeding to treatment, high mean blood pressure, and a large aneurysm.
Aneurysm site, age, number of bleeds, pre-existing hypertension, and evidence of vasospasm were not indicative of higher mortality.
The clinical variables found to be most related to rebleeding included a short interval from the last bleed to treatment and sex (male). Other variables less related to rebleeding but not reaching statistical significance included a high mean blood pressure and the number of bleeds in the medical history. Aneurysm site, initial neurological and medical state, age, aneurysm size, pre-existing hypertension, and evidence of vasospasm did not appear to be related to rebleeding.
The discriminant functions derived were used to reclassify the subjects into dead and alive and rebleeding and no rebleeding 90 days after initial hemorrhage. The misclassification percentages were substantial, making doubtful the prediction of mortality and rebleeding.
REGULATED BED REST was one of four treatment modalities studied in a randomized clinical trial conducted between 1963 and 1970 of patients with a ruptured intracranial aneurysm. The other three treatment programs were: (1) drug-induced hypotension with regulated bed rest, (2) ipsilateral common carotid artery occlusion with bed rest, and (3) intracranial surgery. An introduction to the study, 1 the objectives and design of the study, 2 a comparison of the treatment groups, 3 a detailed analysis of intracranial surgery, 4 and a medical analysis of bed rest 6 have been published. The purpose of this report is to provide a statistical analysis of the clinical factors associated with mortality and rebleeding in those treated with bed rest. Although bed rest therapy alone is outmoded as an early treatment of recently ruptured intracranial aneurysms, the results of this analysis are considered to be of importance, because the outcome of patients treated with regulated bed rest most closely approximates the natural history of the disease.
Methods
Between June 15, 1963 and February 15, 1970, 202 patients were assigned randomly to the regulated bed rest treatment category. All patients except eight completed their designated period of bed rest. Among the remaining 194 patients, 35 had an internal carotid artery aneurysm, 22 had a middle cerebral artery aneurysm, 130 had an anterior cerebral-anterior communicating artery aneurysm, and seven had an aneurysm on the vertebral-basilar arterial system (table 1) . On June 19, 1967, collection of protocols from patients with a vertebral-basilar aneurysm was suspended, and this group was eliminated from all statistical analyses because the sample size was too small.
Patients allocated to the bed rest treatment program remained at regulated bed rest for 21 days following formal initiation of this therapeutic program. Details of the treatment were described in a previous report. 8 Characteristics of the patient sample, including specific aneurysm location, interval from last bleed to treatment, initial neurological condition, initial medical condition, age, sex, blood pressure, size of aneurysm, number of previous bleeds, pre-existing hypertension, and evidence of vasospasm were also presented. 5 The individual effects of selected clinical variables on mortality and rebleeding were analyzed statistically using a method adapted from the transient survivorship analysis of Mantel and Byar. 6 The mortality and rebleeding rates were calculated on the basis of the interval from the day of the last bleed prior to randomization to the day of death or rebleeding. A patient was only considered at risk after the day of randomization. Statistical testing of differences in five-year mortality and rebleed rates was done using a method reported by Koch, Johnson, and Tolley. 7 The reported probability level (p-value) was interpreted as a suggestion of a trend in mortality or rebleeding rate and was not 
REBLEED (PROVED):
First recurrent hemorrhage following the last pre-randomization bleed diagnosed by lumbar puncture or postmortem examination ANETJRYSM-RELATED DEATH: Primary cause of death noted to be from a proved rebleed, an episode highly suggestive of rebleeding, or progressive clinical deterioration from complications of the pre-randomization bleed. NEUROLOGICAL CONDITION on day of randomization: Grade 1 = Symptom -free 2 = Minor symptoms (headache, meningeal irritation, diplopia) 3 = Major neurologic deficit but fully responsive 4 = Impaired state of altertness but capable of protective or other adaptive responses to noxious stimuli 5 = Poorly responsive but with stable vital signs 6 = No response to address or shaking, non-adaptive response to noxious stimuli, and progressive instability of vital signs MEDICAL CONDITION: Good -patients who were alert, normotensive, with no more than a degree of fever, and in good health prior to subarachnoid hemorrhage Fair -patients with a single underlying medical problem such as hypertension, cirrhosis of the liver, advanced age, anemia, poor nutrition, generalized atherosclerosis, or chronic pulmonary disease Poor -patients with more than one adverse factor or one medical condition which was particularly severe Prohibitive -patients with a complicated illness with one or more undesirable conditions considered a test for a hypothesis of no difference in mortality or rebleeding among variables. Adequate sample sizes for testing hypotheses of clinical variables within treatment categories were not specified in the original protocol since the primary purpose of the study was to compare the number of deaths and rebleedings among four treatment modalities. Linear discriminant function analysis was used to develop equations of the clinical variables to predict early mortality and rebleeding. The program used was a modification of the subroutine of La Motte and Hocking 8 which was originally developed for regression analysis. The adaptation was done by Ramberg and Enochson.
8 Misclassification rates for the discriminant analysis were calculated using a procedure reported by Lachenbruch. 10 Results
Mortality
The cumulative mortality, computed from deaths directly related to the ruptured aneurysm, was analyzed during a five-year period following the bleed. Incremental mortality was greatest (29%) during the first month following the initial bleed (table 3) . Between the first and third months the incremental mortality was 9%. Following the initial three month interval, mortality was 3% between three and six months, 1% between six months and one year, and 1% to 3% for each yearly interval thereafter up to five years. At the end of the fifth year, cumulative mortality was 50%.
Rebleeding
Rebleeding during the follow-up interval followed a trend similar to that of mortality (table 6). Thirty percent of the patients rebled during the first month. The increment to cumulative rebleeds was 7% between the first and third months, and 1% between the third and sixth months. The increment also remained at 1% between six months and one year. The incidence of rebleeding varied from 1% to 3% for each yearly interval thereafter up to five years. At the end of the fifth year cumulative rebleeding was 47%.
Effect of Selected Clinical Variables Upon Mortality
Variables with a potential relationship to mortality and rebleeding included the aneurysm site, the interval from last bleeding to treatment, the initial neurological condition, initial medical condition, age, sex, mean blood pressure, size of aneurysm, number of proven and suspected bleedings, preexisting hypertension, and vasospasm. The influence of these variables was analyzed individually with respect to mortality and rebleeding. The combined influence of these variables upon mortality and rebleeding, using the statistical technique of discriminant function analysis, will be described below.
Aneurysm Site
In table 3, cumulative mortality is presented for the aneurysm site. Mortality for patients with a middle cerebral artery aneurysm (47% at the end of one month to 63% at the end of five years) was highest during all follow-up periods. Mortality during the first month for patients with an •Statistical test of the difference in five-year mortality rates based on the mortality rates at each specified interval adjusted for lost-to-follow-up and deaths of unrelated causes.
anterior cerebral-anterior communicating artery aneurysm was less than for patients with an internal carotid aneurysm (26% versus 32%). However, at the end of six months the mortality among patients with an anterior cerebral-anterior communicating aneurysm was similar to that of patients with an internal carotid aneurysm. The percentage of deaths was higher for those with anterior cerebral-anterior communicating artery aneurysm during the one-year to five-year follow-up period. The chi-square test comparing the three mortality curves was not statistically significant (p = 0.596).
Interval from Last Bleeding to Treatment
The interval from last bleeding to treatment (table 3) appeared to be related to mortality. Except for the first time period (1/12 year) when mortality for patients allocated to treatment during the eight-day to 21-day and 22-day to 92-day interval was reversed, mortality declined as the interval from last bleeding to treatment increased. One explanation may be that patients who were more severely ill may have sought treatment sooner than those in better condition.
Also, patients with a longer interval following last bleeding survived the critical early period immediately following a bleeding episode, and may thus have had a better prognosis. The latter hypothesis is more likely because the percentage of patients in poor neurological condition allocated to treatment within the eight-day to 21-day interval was not significantly different from the percentage of patients with the same condition allocated within seven days following last bleed. The overall chi-square test was close to being statistically significant at the 5% level.
Neurological Condition
Patients in good neurological condition (Grades 1 and 2, table 4) had a 24% mortality at the end of one month following last bleeding. Those with more severe initial neurological deficits had a 40% mortality at the end of one month. The cumulative mortality increased in both groups with time. The initial difference in mortality was maintained throughout the five-year period. The overall chi-square test was statistically significant at the 5% level. 
Medical Condition
Initial medical condition on day of randomization was. classified as good, fair, poor and prohibitive (see table 2 for definition). The last two categories were combined because the patient sample was small in each group. A pronounced effect of medical condition upon mortality was observed. One month following last bleeding, mortality among the three groups (good, fair, poor/prohibitive medical conditions) was 20%, 36% and 51%, respectively (table 4). These differences remained unchanged throughout the five-year period, although the cumulative mortalities for patients in good and fair medical condition tended to converge by the end of the fifth year (45% and 50%, respectively). Seventyfive percent of patients in the poor/prohibitive group died during the five-year interval. The overall chi-square test was close to significance at the 5% level (p = 0.073), while the tests for groups taken two at a time were significant at the 5% level.
Age
Patients were divided into four groups by age for purposes of this analysis. These groups included patients whose age was less than 20, 20-39, 40-59, and 60 or over (table 5) . With few exceptions, cumulative mortality increased with age and at each follow-up interval. However, the differences did not reach statistical significance.
Sex
Cumulative mortality with respect to sex is presented in table 5. Males had higher cumulative mortality than females at all follow-up intervals. The differences were small in the early periods, but they increased at later follow-up intervals. The chi-square test was close to significance at the 5% level (p = 0.065).
Mean Blood Pressure
Mean blood pressure is a weighted average of the pretreatment diastolic and systolic pressures, with the systolic having a weight of one and a diastolic having a weight of two. This variable was subdivided into two groups, 1) less than or equal to 110 mm Hg, and 2) greater than 110 mm Hg. Cumulative mortality was greater for patients with higher mean blood pressures at all follow-up intervals (table  4) . The difference in mortality was 10% at one month, 3% at six months, and then the difference increased gradually to 13% at five years. The chi-square test was close to significance (p = 0.157). 
Size of Aneurysm
Aneurysm size was measured in cubic millimeters (volumetric calculation of intraluminal diameters determined from cerebral angiograms), and the group was subdivided into those with aneurysms which were less than or equal to 200 mm 3 , and those over 200 mm 3 . Cumulative mortality was greater for patients with large aneurysms at all followup intervals (table 3 ). The differences in mortality between the two groups increased from 4% at one month to 13% at the 5-year follow-up interval. The chi-square test was close to significance (p = 0.125).
Proved and Suspected Bleedings
Patients with proved and suspected bleedings were subdivided into those with one bleed, and those with two or three bleeds. No patients had more than three proved or suspected rebleedings. Cumulative mortality was greater at all follow-up intervals for the group of patients with two or three bleedings, than for those with only one bleed (table 3) . However, the differences did not reach statistical significance.
Pre-Existing Hypertension*
In table 5, the cumulative mortality is classified by the presence or absence of pre-existing hypertension. Up to one year after the initial bleeding, little or no difference in mortality was found between the two groups. In long-term follow-up (5 years) the hypertensive patients had a slightly higher mortality (53% versus 48%) than the group of nonhypertensive patients. These differences were not statistically significant.
VasospasmĈ
umulative mortality among patients with no cerebral vasospasm and those with localized and diffuse cerebral vasospasm was 29%, 30% and 32%, respectively, at the end of one month (table 4) . During the interval from three months to one year, patients with no vasospasm had a lower mortality than those with localized or diffuse vasospasm. There was little difference in mortality between the groups of patients with localized and diffuse vasospasm. At the end of the five-year follow-up interval, mortality among patients with no vasospasm was identical to those with localized vasospasm (49%), and the patients with diffuse vasospasm exhibited the highest mortality (59%). None of the observed differences was statistically significant.
Summary of Effect of Clinical Variables on Mortality
These data show the mortality in patients with recent subarachnoid hemorrhage following treatment with a three-
•Pre-existing hypertension: existence in patient's history of hypertension (> 160 mm Hg systolic) either treated or untreated.
fVasospasm: was determined on angiograms by the demonstration of decreased intra-arterial size and was categorized as no vasospasm; local vasospasm (narrowing of intra-arterial diameter over one to three centimeters on the proximal segments of the intracranial portion of the internal carotid, middle cerebral, anterior cerebral or vertebral-basilar arteries); and diffuse vasospasm (narrowed diameter of the intracranial internal carotid artery and all the main ipsilateral branches).* week program of regulated bed rest was, over a five-year interval, related to specific clinical variables. The patients with least good prognosis might be characterized as those with:
1 Only initial neurological and medical conditions, and sex were significantly related to mortality on a statistical basis. The remaining seven variables showed trends related to higher mortality. Little or no difference in mortality was found among patients with or without pre-existing hypertension.
Effect of Selected Clinical Variables Upon Rebleeding
Following entry into the study, the patients with recurrent hemorrhage died in the greatest numbers. A statistical analysis was made using selected clinical parameters and relating them to rebleeding. In this analysis, recurrent hemorrhage was proved during hospitalization by lumbar puncture, or in some instances was suspected clinically. In situations where a suspected rebleeding was reported as a cause of death, a precipitous clinical deterioration prior to death was believed to be sufficient evidence for the reporting investigator to regard the cause of death as recurrent hemorrhage even if lumbar puncture or postmortem examination could not be performed.
Aneurysm Site
The cumulative rebleeding rate by aneurysm site was highest among patients with middle cerebral artery aneurysms throughout all follow-up periods (table 6). The rate for anterior cerebral-anterior communicating artery aneurysms was intermediate, and the rate for internal carotid artery aneurysms was lowest. The differences remained uniform throughout the five-year follow-up. Interestingly, the rebleeding rate remained the same during the three-month to four-year interval for patients with an internal carotid (30%) and middle cerebral artery aneurysm (49%). During that same interval, the rebleeding rate for patients with an anterior cerebral-anterior communicating artery aneurysm increased from 37% to 49%. The overall chi-square test was not statistically significant (p = 0.270).
Interval from Last Bleed to Treatment
The interval from last bleed to treatment had a profound effect upon rebleeding rate. Of the 14 patients allocated to regulated bed rest during the 22-day to 92-day interval following the initial bleeding, no patients rebled until the fifth year of follow-up (table 6) . Patients allocated to treatment during the eight-day to 21-day interval had an intermediate rebleeding rate throughout the five-year interval (range 16% to 33%). In contrast, patients allocated to treatment within seven days after an initial bleed had the highest rebleeding rate throughout the follow-up period (range 37% to 55%). The chi-square test was significant at the 5% level (p = 0.046).
Neurological Condition
Cumulative rebleeding rates were analyzed for patients whose neurological condition was recorded initially on the day of randomization. Some patients were reported to be in good neurological condition (Grades 1 & 2, table 7) and the others in poor condition (Grades 3 to 6). Patients with various minor neurological symptoms had a higher rebleeding rate (32%) in the first month than those with a more severe initial neurological condition (25%). This trend was reversed at the third month and continued through the fifth year of follow-up. The differences in rebleeding rates between the two groups were never more than 8%, and the chi-square test was not significant (p = 0.429). These results were in marked contrast to the corresponding results for mortality.
Medical Condition
General medical condition (as defined in table 2) was designated for each patient on the day of randomization. When the medical condition was analyzed with respect to rebleeding rate, no consistent differences in recurrent subarachnoid hemorrhage were found throughout the five-year interval between the respective medical conditions (table 7) . Prior to the third year, patients in fair medical condition had the highest rebleeding rate. Patients in good or poor/prohibitive condition had similar rebleeding rates during that interval which were lower than the rates among patients in fair condition. After the third year of follow-up, the poor/prohibitive patients had the highest rebleeding rate; patients in fair condition had an intermediate rate, and patients in good condition had the lowest rate. The overall chisquare test was not significant (p = 0.432). These results were also in marked contrast to the corresponding results for mortality.
Age
Selected age groups were compared with respect to rebleeding rates throughout the five-year interval. Neglecting the constant 40% rebleeding rate for the age group under 20 because of the small sample size (n = 6), there was a trend toward an increased rebleeding rate with advanced age (table 8). The age-group 20-39 consistently had the lowest rebleeding rate, while the age groups 40-59 and 60 and above had the highest rates. However, the differences were not statistically significant.
Sex
Men consistently had a higher rebleeding rate than women (table 8). The differences were small within the first year of follow-up, but they increased appreciably during the second through the fifth year of the follow-up (from 5% at year one to 17% at year five). The difference in mortality curves was close to statistical significance (p = 0.059).
Mean Blood Pressure
Patients with mean blood pressure greater than 110 mm Hg at randomization had a higher rebleed rate than those with a mean pressure of less than 110 mm Hg. The difference was large in the first month (36% versus 27%, respectively, table 7). However, this proportion diminished to a difference of one percentage point at the end of the first year (40% versus 39%, respectively), but increased again by the end of the fifth year (54% versus 44%, respectively). The chi-square test was not significant (p = 0.216).
Size of Aneurysm
During the first month following bleeding, patients with an aneurysm size of less than 200 mm 3 had a rebleeding rate of 35% compared to 31% for patients with aneurysms greater than 200 mm 3 (table 6) . At the end of the third month, rebleeding rates were 39% in both groups. After the third month, the rebleeding rate was higher in the group with large aneurysms, reaching a difference of seven percentage points by the fifth year. The difference in mortality curves was not statistically significant (p = 0.445).
Number of Proved or Suspected Bleeds in History
Patients having multiple bleeds had consistently higher rebleeding rates throughout the five-year follow-up period as compared to those having one bleeding in their history (table 6). The difference in mortality curves was close to statistical significance (p = 0.163).
Pre-existing Hypertension
The rebleeding rate was 29% for those patients with or without preexisting hypertension at the end of the first month (table 8) . From the third month through the fifth year of follow-up, patients with preexisting hypertension had a higher rebleeding rate, the difference varying between two and six percentage points. Statistical significance was not reached (p = 0.498).
Vasospasm
No consistent differences in rebleeding rates were observed among patients with variable degrees of vasospasm (table 7) . The rate was occasionally higher among patients without vasospasm than for those with vasospasm.
Summary of Effect of Selected Clinical Variables upon Rebleeding
Well-defined relationships between patient characteristics and rebleeding rates were fewer than between these same patient characteristics and mortality. Patients treated with regulated bed rest had the poorest prognosis in terms of the following characteristics:
1. Middle cerebral artery aneurysms 2. Early presentation for treatment 3. Advanced age 4. Male sex 5. High mean blood pressure 6. Multiple proven or suspected bleeds 7. Pre-existing hypertension Only the interval from last bleeding to treatment and sex distribution reached statistical significance. The variables below showed no consistent relationship to the rebleeding rate, initial neurological condition, initial medical condition, aneurysm size, and degree of vasospasm.
Prediction of Mortality and Rebleeding
We sought to derive a linear function of the eleven factors considered in the previous sections which would predict the prognosis of a patient with a ruptured intracranial aneurysm treated with bed rest. Outcome is determined by mortality and rebleeding within 90 days after initiation of treatment. The statistical methodology used has been previously described. Since aneurysm site is a three category, nominal variable, it is included as two separate variables for the purposes of these analyses.
The variables and their corresponding abbreviations and codings are given below as used for tables 9-11: The results of the discriminant analyses for the prediction of 90-day mortality are presented in table 10. Only those cases with complete information on all variables were used (n = 145). A discriminant analysis was done for each number of variables from one to twelve; at each step the analysis chose the combination of variables which best discriminates between the patients who died versus those who survived. Table 10 gives the coefficients for the variables chosen and the constant term in the linear equation.
An example for the use of these results is as follows: Suppose one wishes to use the best six variables to predict a patient's survival status at 90 days. These variables are aneurysm site, interval from last bleeding to randomization, initial medical condition, mean arterial blood pressure, presence or absence of pre-existing hypertension, and vasospasm (six variables, table 10). Suppose, further, that a patient had the following scores on these six variables: Middle cerebral artery aneurysm = 1, interval from last bleeding to randomization = 5 days, poor medical condition = 3, mean arterial blood pressure = 108 mm Hg, presence of hypertension = 1, and no vasospasm = When a patient's discriminant score is greater than zero, death within 90 days is predicted; when the score is negative, survival is predicted. Since the patient's score is +0.6572, his death within the first 90 days is more likely than his survival, and some means of treatment might be indicated.
Discriminant scores were computed for the 145 patients, and these patients (for whom the survival status at 90 days was already known) were classified into deceased and survivors. The overall percent misclassification ranged between 37.9% and 44.1% for the 12 discriminant analyses. Misclassification of the patients who were deceased at 90 days ranged from 19.9% to 47.2% and misclassification of the patients who were alive at 90 days ranged from 41.3% to 57.6%.
Order of entry of the variables in the 12 discriminant analyses gives some indication about the relative importance of the variables in predicting mortality. The interval from last bleeding to randomization, medical condition, vasospasm, mean arterial blood pressure, pre-existing hypertension, and middle cerebral arterx aneurysm seem to be the best predictors. Internal carotid artery aneurysm, age, sex, aneurysm size, number of previous bleeds, and neurological condition entered at later stages. Neurological condition probably entered artifically at a very late stage because the information contained in this variable was largely accounted for by medical condition which entered at an early stage.
The results of the discriminant analyses for the prediction of 90-day rebleeding are presented in table 11. The interval from last bleeding to randomization again appears to be the most significant predictor of outcome. Other variables which contribute most to prediction of rebleeding include vasospasm, aneurysm size, middle cerebral artery aneurysm, and mean arterial blood pressure. However, the direction of the relationship between rebleeding and the former two factors is contrary to intuition (i.e., rebleeding is more likely with a smaller aneurysm size and no vasospasm). When the 145 patients are classified by the discriminant equations, the overall percent misclassification ranges from 37.9% to 46.2%. Misclassification of the patients who rebled during the 90-day period ranged from 16.3% to 40.8%, and misclassification of the patients who did not rebleed ranged from 46.9% to 57.3%.
Discussion
Mortality and rebleeding rates during a five-year period were analyzed by a life table method of statistical analysis following a three week period of bed rest in patients with a recently ruptured aneurysm. Linear discriminant function analysis was used to develop equations of clinical variables which could be utilized to predict mortality and rebleeding.
Five years following subarachnoid hemorrhage, 50% of all patients were dead from causes directly related to aneurysm rupture. A total of 47% rebled. The incidence of death or rebleeding varied from 1% to 3% for each yearly interval between 6 months and five years.
The mortality and rebleeding rates among patients with internal carotid artery aneurysms remained unchanged (38% and 30%, respectively) during the period between 3 months and 5 years following the initial bleeding. In contrast, mortality and rebleeding rates among patients with an anterior cerebral-anterior communicating artery aneurysm increased progressively during the five-year interval. The results of mortality and rebleeding rates among patients with a middle cerebral artery aneurysm were the poorest among the three aneurysm sites. However, the number of patients included with aneurysm at this site (22) was less than the number of patients at the remaining two sites.
The interval from last bleeding to treatment had a highly significant relationship to death and rebleeding. This fact is related to the known observation that recurrent hemorrhages and deaths from the original bleeding occur at a peak incidence between five and ten days following the original bleeding.
Cumulative mortality and recurrent hemorrhage increased during the five-year follow-up period in patients with both good and poor neurological condition. Patients with poor neurological condition had a higher mortality than those in good condition. The patient's medical condition had a similar relation between mortality and rebleeding patterns and good, fair, and poor/prohibitive medical condition as observed for patients with different neurological conditions. The unexpected finding was that patients in fair condition (patients with a single underlying medical problem) had higher mortality and rebleeding rates throughout the fiveyear period than patients in good condition.
With few exceptions, cumulative mortality and rebleeding rates increased with age. Throughout the five-year period, men had a higher mortality and rebleeding rate than women. Furthermore, higher mean blood pressure at randomization carried a worse prognosis for both mortality and rebleeding.
Cumulative mortality was greater in patients with large aneurysms than small aneurysms (< 200 mm 3 ) at all followup intervals. The differences in mortality were greater than those observed for cumulative rebleeding rate. Patients with multiple bleedings prior to hospitalization had consistently higher mortality and rebleeding rates than the group of patients with one bleeding. The presence of pre-existing hypertension was not strongly associated with a higher mortality and rebleeding rate during the five-year period. The percentage of deaths and rebleedings was only slightly higher in the hypertensive group. Patients with diffuse vasospasm tended to have higher mortality than those with no vasospasm or local vasospasm. However, no consistent differences in rebleeding rates were observed among patients with various degrees of vasospasm during the five-year period.
The relationships among selected clinical characteristics, mortality, and rebleeding rate had a high degree of association. The order of importance of the clinical variables was similar for cumulative mortality and rebleeding rate. The major exceptions were neurological and medical conditions which were more significant in the prognosis associated with cumulative mortality, than with cumulative rebleeding rate.
These data were derived from patients who were randomly allocated to regulated bed rest in the Cooperative Aneurysm Study conducted between June, 1963 and February, 1970 . Comparison of these results with others should be done with caution since most other patient samples reported in the literature result from a selected series rather than from randomization. However, a randomized study design comparable to that described in this paper was reported by Winn, et al." Their data indicate that deaths from rebleeding occur an average of 4% to 6% per year. Furthermore, elevated systolic blood pressure had a higher association with recurrent hemorrhage than that demonstrated in patients from the Cooperative Study. Our study demonstrated mortality from recurrent hemorrhage to vary from 1% to 3% per year after the first six-month period following the bleeding, and that the interval from last bleeding to treatment, initial neurological and medical conditions, and sex distribution had a higher association with mortality than blood pressure. Our calculations of mean blood pressure included those at the time of the original bleed.
Discriminant function analysis has also been applied to data from patients with recently ruptured cerebral aneurysm by Richardson, et al. 12 ' I3 However, their method of analysis and the prognostic factors used in their study differed from those used in this report. Because recently ruptured middle cerebral artery aneurysms were not evaluated in their studies, detailed comparison of aneurysm site must be deferred. Notwithstanding, prognosis in our patients with an anterior cerebral-anterior communicating artery aneurysm was worse during the three-month to five-year interval (tables 3 and 6) when compared to the group with internal carotid artery aneurysm. Our patients with an internal carotid artery aneurysm had a better prognosis than those reported by Richardson, et al. 12 The neurological and medical conditions had a high degree of influence on mortality in the Cooperative Study, but the level of consciousness in Richardson's study appeared to have less importance.
Review and analysis of these data suggest that multiple clinical variables can be useful when an attending physician must discuss and evaluate specific treatment programs for patients with recent subarachnoid hemorrhage. The interval following last bleed, initial neurological and medical conditions, sex, and mean blood pressure possess the highest value in assessment of long-term prognosis for patients with recently ruptured aneurysm according to our study.
Linear discriminant function analysis was used to develop equations which would best predict mortality and rebleeding. The misclassification rates were substantial, indicating that the practicality of these equations may be doubtful for making specific clinical judgments at the bedside.
Conclusions
The purpose of this report was to describe the effect of various factors on the outcome of 187 patients having a ruptured intracranial artery aneurysm and treated with regulated bed rest, and to develop linear equations of these factors which could best predict outcome. These factors included aneurysm site, interval from last bleeding to treatment, initial neurological condition, initial medical condition, age, sex, mean blood pressure, aneurysm size, number of previous bleedings, preexisting hypertension, and evidence of vasospasm. Outcome was determined by survival status and rebleeding.
The variables which were found to be most indicative of mortality included: A short interval from last bleeding to treatment; poor initial neurological and medical condition; high mean blood pressure; sex (male); and large aneurysm size. Interval from last bleeding to treatment, sex, mean blood pressure, and number of bleedings in medical history were most indicative of rebleeding.
Linear equations for any number of variables (one to twelve) were developed which best predicted mortality and rebleeding. The original patients used to develop these equations were reclassified using the equations as a test of the usefulness of the equations. The misclassification rates were substantial, indicating that the practicality of these equations is doubtful for use as a basis for making clinical judgments. These results underscore further the complexity of the problem of determining accurately the prognosis of patients with ruptured intracranial aneurysms on a statistical basis.
S U M M A R Y Increasing evidence suggests that higher blood velocity, by causing turbulence and high shear rates at the endothelial surfaces of arteries, may be important in the pathogenesis of atherosclerosis. In order to measure the effects of antihypertensive agents on blood velocity, an improved method has been developed for analysis of Doppler ultrasound velocity recordings. The audio signal from a Doppler velocity meter is subjected to spectral analysis; the sonagraph thus obtained is digitized with the use of a magnetic table on-line with a calculator. Four monkeys were maintained at a hypertensive baseline for six weeks by infusion of angiotensin and isoproterenol. The effects on blood velocity of 72-hour infusions of propranolol, clonidine, hydralazine, and methyldopa were studied. In doses that reduced diastolic pressure by 13-28%, propranolol decreased mean blood velocity (mv) by 17%, clonidine decreased mv by 14%, while methyldopa increased mv 12%, and hydralazine increased mv by 52% (p < .00001). Antihypertensive drugs appear to have different effects on blood velocity; these differences may influence choice of antihypertensive drugs for the prevention of arterial disease.
THEORIES ON the pathogenesis of atherosclerosis cite multiple factors that may initiate and perpetuate the lesions in arterial walls. 1 Various roles might be played by platelets, smooth muscle cells, and lipids in blood.
In 1856, 2 Virchow postulated that mechanical irritation of the intima was the initial event in the process of atherosclerosis. His concepts have been extended in more precise terms such that we now believe these hydromechanical forces at the interface between the circulating blood and the vessel wall, in the form of turbulence and shear stress, may be important pathogenetic factors in atherosclerosis. 3 " 5 The relative contribution of such forces vis-a-vis the role of platelets, smooth muscle cells, and lipids in the arterial lesions has not been defined. 6 We now know that treating high blood pressure in some way(s) helps prevent arterial disease. We have, however, given little consideration to the possibility that drugs that lower blood pressure may have differing effects on blood velocity and that these varying actions may contribute to the development of turbulence and shear. No a priori reason exists to assume that all drug combinations will offer equal efficacy in the prevention of atherosclerosis, even though they may lower blood pressure to the same degree.
This study develops an experimental approach that might be used in man to test the efficacy of various combinations of antihypertensive drugs in preventing atherosclerosis, and to assign the role played by their effects on blood velocity. We present the methods used to determine blood velocity and preliminary data generated from rhesus monkeys (that were made hypertensive by pharmacologic manipulation) while they received each of four commonly used antihypertensive drugs, at doses sufficient to produce a hypotensive response.
Methods

Animals and Apparatus
Four male monkeys (Macaca mulatta), weighing from 4 to 6 kg, were anesthetized with pentobarbital (30 mg/kg). Sterile polyvinyl catheters for infusion of drugs and for recording pressures were inserted into the left iliac artery and vein, tunneled subcutaneously, and brought out through the skin near the umbilicus. Through a vertical incision medial to the left sternocleidomastoid muscle, the left common carotid artery was dissected clear, and the bifurcation into internal and external carotid was identified. A 2 mm periarterial cuff Doppler probe (Parks Electronics, Beaverton, Oregon) was placed around the artery, tied closed, and sutured in place 1 cm below the bifurcation. Care was taken to avoid twisting or compressing the artery. The wires from the Doppler probe were tunneled subcutaneously and brought out through the skin near the umbilicus. Postoperatively the monkeys were placed in primate restraining chairs inside sound-protected isolation booths. The catheters, brought to the outside of the booth, were flushed continuously with lightly heparinized (5 USP units/ml) 0.9%
